Citeline Podcasts

Norstella
Norstella
  • 4.2 (30)
  • Business
  • Updated Daily

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

  1. 10h ago

    Counting Self-Care’s Triple Win, With GSCF’s Greg Perry And Ben Carrick

    The Global Self-Care Federation has updated its analysis of the health, social and economic value of self-care, using data from 155 countries. Savings to health systems are up 21% to around $144bn a year, and for the first time the report looks in detail at self-care’s role in prevention. GSCF director general Greg Perry and Ben Carrick, co-chair of the federation’s policy committee, join HBW Insight on the Over the Counter podcast to talk through the findings. Carrick, who also works in global public and government affairs at Kenvue, worked on both editions of the study. We discuss what has changed since 2022, why a single OTC pack in North America is worth around $362 in welfare gains, who should pay for self-care in poorer countries, and what GSCF wants governments, regulators and pharmacists to do next.

    Counting Self-Care’s Triple Win, With GSCF’s Greg Perry And Ben Carrick

  2. 3d ago

    Drug Fix: CMS Finalizes GLOBE Model And US FDA Adcomm, Personnel Changes

    Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Senior Writer Cathy Kelly discuss the limited impact the US Centers for Medicare and Medicaid Services’ Global Benchmark for Efficient Drug Pricing (GLOBE) model after it was finalized with only a handful of participants (:58), as well as several other questions still being asked about it (10:24). They also consider the impact of the Food and Drug Administration eliminating voting privileges for some advisory committee consumer representatives (15:15), the Health and Human Services Department eliminating some of the FDA’s legal oversight (24:13), and the FDA reopening its search for a cell and gene therapy office director (27:28). More On These Topics From The Pink Sheet Shrinking GLOBE: Medicare Part B Model Seems Increasingly Unlikely To Advance: ⁠https://insights.citeline.com/pink-sheet/market-access/pricing-debate/shrinking-globe-medicare-part-b-model-seems-increasingly-unlikely-to-advance-2MFLVAIRWRG7JDEZQP2AQ7VZMY/⁠ Possible GLOBE Participants Down To Four ... And Counting: ⁠https://insights.citeline.com/pink-sheet/market-access/pricing-debate/possible-globe-participants-down-to-four-and-counting-4UYTIWXLRNAMXEIR7JNTRCNR3Q/⁠ US FDA Wants Advisory Committee Members, But Not Voting Consumer Reps: ⁠https://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/us-fda-wants-advisory-committee-members-but-not-voting-consumer-reps-5V4SKVJFB5FJLG2GPKKZJXZVLY/⁠ Reorg Cuts US FDA Chief Counsel Oversight Position At HHS: ⁠https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/reorg-cuts-us-fda-chief-counsel-oversight-position-at-hhs-5VPOXSOOLRCCVPGWEI2XECL6UE/⁠ US FDA Continues Search For Cell, Gene Therapy Office Director, Lowers Education Requirement: ⁠https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/us-fda-continues-search-for-cell-gene-therapy-office-director-lowers-education-requirement-IXJCWUATZBHKZLOTNFSCJBOHYE/

    Drug Fix: CMS Finalizes GLOBE Model And US FDA Adcomm, Personnel Changes

  3. 3d ago

    Proof of Concept - Can AI Outrun the Next Outbreak?

    What if you could design a diagnostic and a therapeutic directly from a pathogen's genetic code, faster than the disease can spread? Jared Bauer, co-founder and CEO of Seek Labs, joins Proof of Concept to explain how his company's AI engine maps conserved targets across 145+ pathogens to build programmable CRISPR therapeutics and rapid, lab-free diagnostics.

    Proof of Concept - Can AI Outrun the Next Outbreak?

  4. 5d ago

    【3分で解説 #世界のファーマ】第31回　中国、バイオ医薬品の成長に本腰　初の5カ年計画 (Japanese-language podcast) Sept. 30, 2026

    世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら Six Chinese Drugs On Course For Blockbuster Status As Five-Year Plan Sets The Bar https://insights.citeline.com/scrip/focus-on-asia/china/six-chinese-drugs-on-course-for-blockbuster-status-as-five-year-plan-sets-the-bar-KEBII2JIZNC7RIE2KMLCA2O4D4/ China Eyes Central Role On Global Biopharma Stage https://insights.citeline.com/pink-sheet/geography/asia/china/china-eyes-central-role-on-global-biopharma-stage-NWR3FDT5ZJBB3A53YZEGGJW7RI/ ※全文の閲覧には購読（有料）が必要です。世界の製薬ビジネスメディアScrip（スクリップ）とは？https://www.citeline.com/ja-jp/products-services/commercialization/scrip

  5. Sep 28

    Strategic Intent: Boehringer Ingelheim's Brian Hilberdink on Launching Into the GLP-1 Era

    Brian Hilberdink, President of US Human Pharma at Boehringer Ingelheim, joined Strategic Intent to talk about leading one of the company's most ambitious US launch periods in years, spanning a specialty drug in interstitial lung disease, an established franchise in cardiometabolic disease and a potential entry into the hyper-competitive obesity market. He discusses how private ownership shapes long-term decision-making, why he wants to reframe the obesity conversation away from the scale and toward metabolic health, how the payer landscape has fundamentally changed since he started in the industry, and what role AI will play in the future of commercialization.

  6. Sep 25

    Drug Fix: Lessons From US FDA Commissioner Nominee Heidi Overton’s Confirmation Hearing

    Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs dissect US Food and Drug Administration commissioner nominee Heidi Overton’s answers during her Senate confirmation hearing and dominant themes (:58), rate the potential for her confirmation (13:14), as well as consider her responses to particular controversial issues like mifepristone safety (16:06) and more practical issues like advisory committee meetings (21:23). They also look at the remaining hurdles for Overton’s bid to take control of the agency (24:40). More On These Topics From The Pink Sheet Overton Calls MMR Vaccine ‘Not Lethal,’ Defends Trump’s Claim As Outreach To Vaccine Skeptics: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/overton-calls-mmr-vaccine-not-lethal-defends-trumps-claim-as-outreach-to-vaccine-skeptics-TO3WNT3NUZGJ5IDRRUBDHF5CIA/ US FDA Commissioner Nominee Overton Says Adcomms ‘Critical,’ Hedges On Mifepristone Safety: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fda-commissioner-nominee-overton-says-panels-are-critical-hedges-on-mifepristone-safety-RGSODPP5IRHLDA7A26TGOZ7LRI/ Former FDA Commissioners’ Backing May Help Overton Amid Stakeholder Opposition: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/former-fda-commissioners-backing-may-help-overton-amid-stakeholder-opposition-66MIFWT47ZDKDLYEFSBHMUEOEE/

    Drug Fix: Lessons From US FDA Commissioner Nominee Heidi Overton’s Confirmation Hearing

  7. Sep 24

    Assessing the current dealmaking environment for psychedelic medicine.

    Joseph Haas and Emma Wille overview the dealmaking environment for psychedelic medicine given recent developments in the space: Eli Lilly's $2.8 billion acquisition of AtaiBeckley in July, the imminent FDA filing of Compass Pathways' COMP360 for treatment-resistant depression and a more relaxed regulatory environment for psychedelic therapies under the current administration.

    Assessing the current dealmaking environment for psychedelic medicine.

  8. Sep 24

    Advancing CNS Drug Development Through AI, New Approach Methodologies and Regulatory Innovation

    Citeline Podcasts

See All (626)

4.2
out of 5
30 Ratings

About

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Information

  • Channel
    Norstella
  • Creator
    Norstella
  • Years Active
    2014 - 2026
  • Episodes
    652
  • Rating
    Clean
  • Copyright
    © 24c12740-34d6-11f1-9889-f71e988e8a77
  • Show Website
    Citeline Podcasts

More From Norstella

You Might Also Like